Zepbound costs $25 per month with commercial insurance and the Lilly Savings Card, or $299 per month through LillyDirect self-pay for the 2.5 mg starter dose. The retail list price is about $1,086 per month. Most patients pay between $25 and $499 per month in 2026, depending on insurance, dose, and which Eli Lilly program they use. This guide breaks down every Zepbound pricing path for 2026.
Key takeaways
- Zepbound list price is around $1,086 per month at retail pharmacies in 2026.
- The Lilly Savings Card drops the copay to $25/month for eligible patients with commercial insurance.
- LillyDirect self-pay vials cost $299/month for 2.5 mg and $399/month for 5 mg in 2026.
- Higher doses (7.5–15 mg) cost $449/month through the Self Pay Journey Program.
- The Medicare GLP-1 Bridge launched July 1, 2026, capping Zepbound at about $50/month.
- Income-qualifying uninsured patients may get Zepbound free via Lilly Cares.
- LillyDirect self-pay covers vials only — KwikPen prices remain higher.
What is Zepbound?
Zepbound is the brand name for tirzepatide injection approved for chronic weight management. Eli Lilly makes it, and the FDA approved it in November 2023. It is the same active drug as Mounjaro, but with a different label and weight-loss-focused indication.
Tirzepatide is a dual GLP-1 and GIP receptor agonist. The double action gives it stronger weight loss results than older GLP-1 drugs. The cost difference between Zepbound and Mounjaro reflects insurance category, not pharmacology.
How much does Zepbound cost in 2026?
Zepbound costs between $25 and $1,086 per month in 2026. The exact price depends on your insurance, the dose, and the Eli Lilly program you use. The table below shows the main payment channels.
| How you pay | Monthly cost | Who qualifies |
|---|---|---|
| Commercial insurance + Lilly Savings Card | $25/month | Private insurance with Zepbound coverage |
| Commercial insurance, no Zepbound coverage | Up to ~$517/month | Private insurance, plan excludes weight loss drugs |
| LillyDirect self-pay (vials) | $299–$699/month | Anyone with a valid prescription, no insurance needed |
| Medicare GLP-1 Bridge (from July 2026) | ~$50/month | Medicare Part D beneficiaries with qualifying obesity |
| Lilly Cares Patient Assistance | $0/month | Income-qualifying uninsured patients |
| Retail without coverage | ~$1,086/month | Patients paying list price (rare in 2026) |
Most patients now pay between $25 and $499 per month. Few people pay the full retail list price thanks to manufacturer programs and broader insurance coverage in 2026.
Zepbound cost without insurance
Zepbound costs $299–$699 per month without insurance through LillyDirect, depending on the dose. The retail pharmacy list price is $1,086.37 per month for the KwikPen. Few patients now pay retail.
Eli Lilly’s LillyDirect platform sells single-dose vials directly to patients with a valid prescription. The price is the same whether you order home delivery or pick up at Walmart pharmacy. The table below shows current LillyDirect pricing for each dose.
| Dose | Monthly price | Notes |
|---|---|---|
| 2.5 mg (starter) | $299 | Standard pricing |
| 5 mg | $399 | Standard pricing |
| 7.5 mg | $449 or $499 | $449 via Self Pay Journey (45-day refill) |
| 10 mg | $449 or $699 | $449 via Self Pay Journey (45-day refill) |
| 12.5 mg | $449 or $849 | $449 via Self Pay Journey (45-day refill) |
| 15 mg | $449 or $1,049 | $449 via Self Pay Journey (45-day refill) |
The Self Pay Journey Program caps higher doses (7.5–15 mg) at $449/month. To keep this price, you must refill within 45 days of your previous delivery. Miss the window and you pay the standard price: $499 for 7.5 mg, $699 for 10 mg, $849 for 12.5 mg, and $1,049 for 15 mg.
Zepbound cost with insurance
Zepbound costs $25 per month with commercial insurance and the Lilly Savings Card. Lilly covers up to $100 per month of your copay. The savings card runs through December 31, 2026, with possible renewal.
Your Zepbound cost with insurance depends on three things:
- Coverage tier: Plans put Zepbound on tiers 3 or 4. Higher tiers mean higher copays.
- Annual deductible: You may pay full price until you meet your deductible.
- Prior authorization: More than 90% of commercial plans require this before covering Zepbound.
If your insurance does not cover Zepbound, the savings card cuts the cost by up to $620/month. You still pay roughly $499/month under that path. LillyDirect self-pay at $299 is cheaper for most uncovered patients.
Zepbound and Medicare in 2026
Medicare Part D started covering Zepbound on July 1, 2026, through the new GLP-1 Bridge program. Eligible Medicare beneficiaries pay about $35–$50 per month for weight loss treatment with Zepbound.
To qualify, you need a documented BMI in the obesity range and a related condition such as type 2 diabetes, hypertension, or sleep apnea. Each Part D plan handles prior authorization differently. Most plans process these requests through the Bridge framework.
Medicare and Medicaid patients cannot use the Lilly Savings Card, since federal law bars it. They can still pay cash through LillyDirect outside their government plan.
Lilly Cares Patient Assistance program
Lilly Cares provides free Zepbound to income-qualifying uninsured patients. The Lilly Cares Foundation runs the program. Eligibility depends on household income, US residency, and lack of prescription drug coverage.
Most approved patients pay $0 per month for up to 12 months at a time. You can reapply once approved. Apply through your healthcare provider or directly at the Lilly Cares Foundation website.
Zepbound cost vs other GLP-1 weight loss drugs
Zepbound is one of several FDA-approved GLP-1 weight loss medications. The table below compares 2026 pricing across the main options.
| Drug | Manufacturer | Self-pay (lowest) | With insurance + card | List price |
|---|---|---|---|---|
| Zepbound | Eli Lilly | $299/mo | $25/mo | ~$1,086 |
| Wegovy | Novo Nordisk | $349/mo | $25/mo | ~$1,349 |
| Wegovy HD 7.2 mg | Novo Nordisk | $399/mo | $25/mo | ~$1,349 |
| Wegovy pill | Novo Nordisk | $149/mo | $25/mo | ~$1,349 |
| Mounjaro | Eli Lilly | Not for weight loss | Varies | ~$1,086 |
Zepbound has the lowest self-pay price among injectable GLP-1 drugs. Wegovy pills start lower at $149/month but treat a different indication and use a daily oral dose. With insurance, all major GLP-1s cost about $25/month thanks to manufacturer savings cards.
How to save money on Zepbound in 2026
Most patients can cut Zepbound costs to under $300/month using one of six strategies. Pick the path that matches your insurance status.
- Use the Lilly Savings Card. If you have commercial insurance with Zepbound coverage, this brings the copay to $25/month.
- Switch to LillyDirect vials. Self-pay vials cost $299–$449/month, often cheaper than insurance copays.
- Apply for Lilly Cares. Uninsured patients with qualifying income may get Zepbound free for 12 months.
- Enroll in the Medicare GLP-1 Bridge. If you have Medicare Part D, you may pay $50/month with qualifying conditions.
- Refill within 45 days. The LillyDirect Self Pay Journey Program requires a 45-day refill window to keep prices low.
- Use HSA or FSA funds. Zepbound qualifies as a medical expense, making pre-tax dollars work for it.
Why does Zepbound cost so much?
Zepbound is expensive because it is a newer biologic drug protected by patents. Manufacturing tirzepatide requires complex synthesis and cold-chain storage. Eli Lilly has invested billions in clinical trials and production capacity. Patent protection runs into the 2030s, so generic versions are not near.
Insurance companies often exclude weight loss drugs from coverage. They are not classified as essential treatments under most plans. This left many patients paying out of pocket until LillyDirect launched in 2024. The 2026 expansion of Medicare coverage and lower self-pay prices reflect industry pressure to make Zepbound more affordable.
Conclusion
Zepbound pricing in 2026 ranges from $25 to $1,086 per month, but most patients pay between $25 and $499. The Lilly Savings Card, LillyDirect self-pay, and the new Medicare Bridge program have brought brand-name Zepbound within reach for more people than ever before.
If you are unsure which path fits your situation, a licensed provider can walk you through the options. Book a free consultation with Heally to get a Zepbound prescription and a personalized savings plan in one visit. For more on Lilly’s 2026 discount programs, see our Zepbound discounts guide.
FAQ
How much does Zepbound cost per month in 2026?
Zepbound costs $25/month with commercial insurance and the Lilly Savings Card. Self-pay through LillyDirect runs $299–$449/month. Medicare beneficiaries pay about $50/month through the GLP-1 Bridge. The retail list price is $1,086/month.
How much does Zepbound cost without insurance?
Without insurance, Zepbound costs $299/month for the 2.5 mg starter vial through LillyDirect, $399/month for 5 mg, and $449/month for higher doses with refill within 45 days. Pen pricing at retail is $1,086/month.
Does Medicare cover Zepbound in 2026?
Yes. The Medicare GLP-1 Bridge program launched July 1, 2026. Eligible Part D members pay $35–$50/month for Zepbound with documented obesity and a weight-related condition. Each plan handles prior authorization separately.
How do I get Zepbound for $25 a month?
Use the Lilly Savings Card. You need commercial (non-government) insurance with Zepbound on the formulary. Enroll at zepbound.lilly.com, give the card to your pharmacy, and present it at each refill. The card runs through December 31, 2026.
What is LillyDirect and how does it work?
LillyDirect is Eli Lilly’s direct-to-consumer platform. You get a Zepbound vial prescription routed to LillyDirect Pharmacy Solutions, choose home delivery or Walmart pickup, and pay self-pay rates from $299/month. No insurance is needed.
Why is Zepbound cheaper than Wegovy through self-pay?
LillyDirect sells Zepbound vials at $299/month for the starter dose. Wegovy’s lowest self-pay price is $349/month for the 2.5 mg starter pen. Lilly offers vials, which cost less to make than prefilled pens.
Will Zepbound get cheaper in 2027?
Probably, yes. Manufacturer competition and Medicare coverage are pushing prices down. Compounded tirzepatide is no longer widely available, so Eli Lilly faces pressure from telehealth platforms and Novo Nordisk. Industry analysts expect further LillyDirect price cuts in 2027.
Can I switch from Mounjaro to Zepbound to save money?
Mounjaro and Zepbound contain the same drug, tirzepatide. Mounjaro is approved for type 2 diabetes only. If you take Mounjaro off-label for weight loss, switching to Zepbound may unlock the Lilly Savings Card and LillyDirect access. Talk to your prescriber.
Sources
- Eli Lilly — LillyDirect Zepbound self-pay terms and conditions (2026)
- Eli Lilly — Lilly lowers Zepbound vial prices via LillyDirect (December 2025)
- Walmart Corporate — LillyDirect and Walmart Pharmacy partnership announcement
- Drugs.com — How much does Zepbound cost in 2026? (medically reviewed)
- FDA — Zepbound (tirzepatide) prescribing information
- Lilly Cares Foundation — Patient Assistance Program for Eli Lilly medications
Important regulatory update
On March 19, 2025, the FDA ended enforcement discretion for compounded tirzepatide. Most pharmacies can no longer legally compound tirzepatide, as the FDA confirmed no drug shortage exists. Patients should use FDA-approved Zepbound or Mounjaro unless a clinician confirms medical necessity for a compounded version.
Medical disclaimer
This article is for informational purposes only and does not replace medical advice. Pricing is current as of May 2026 and may change. Always consult a licensed healthcare provider before starting, stopping, or changing a prescription medication. Individual results and out-of-pocket costs vary.
